LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 13 Oct 2026
MHRA approval

Onswik (insulin efsitora alfa)

Published on 13 Oct 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.
MHRA announcement ↗ All events: Onswik (insulin efsitora alfa)

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.